MKI67 and colonic neoplasm: In NSCLC and RCC patients Ki-67 seems prognostic and in near future the description of the immune infiltrate at the M/BP-interface could be of negative predictive value for immune checkpoint modulation therapies of melanoma, lung, breast and colon cancer patients with brain metastases.